Abbott and AbbVie Announce Investor Calls

                  Abbott and AbbVie Announce Investor Calls

- Abbott will host a conference call to discuss Q4 and full-year 2012 business
results and 2013 outlook on Jan. 23, 2013

- AbbVie will host a conference call to discuss 2012 business results and 2013
outlook on Jan. 30, 2013

PR Newswire

ABBOTT PARK, Ill. and NORTH CHICAGO, Ill., Jan. 14, 2013

ABBOTT PARK, Ill. and NORTH CHICAGO, Ill., Jan. 14, 2013 /PRNewswire/ --
Abbott (NYSE: ABT)will announce its fourth-quarter and full-year 2012
financial results on Wednesday,Jan. 23, 2013, before the market opens.

Abbott's quarterly and annual results will include contributions from the
company's former research-based pharmaceutical business, which became AbbVie
onJan. 1, 2013. While these results will be captured in a single press
release, both companies will host separate conference calls to discuss their
respective business results and 2013 outlooks.

Abbott will host a live webcast of the earnings conference call at 8 a.m.
Central time (9 a.m. Eastern) on Jan. 23, 2013. It will be accessible through
Abbott's Investor Relations website at www.abbottinvestor.com. An archived
edition of the call will be available after 11 a.m. Central time.

On Wednesday, Jan. 30, 2013, AbbVie will host a live webcast at 8 a.m. Central
time (9 a.m. Eastern) accessible through AbbVie's Investor Relations website
at www.abbvieinvestor.com. An archived edition of the call will be available
after 11 a.m. Central time.

About Abbott

Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of
healthcare.With a portfolio of leading, science-based offerings in
diagnostics, medical devices, nutritionals and branded generic
pharmaceuticals, Abbott serves people in more than 150 countries and employs
approximately 70,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

About AbbVie

AbbVie (NYSE: ABBV)is a global, research-based biopharmaceutical company
formed in 2013 following separation from Abbott. With its 125-year history,
the company's mission is to use its expertise, dedicated people and unique
approach to innovation to develop and market advanced therapies that address
some of the world's most complex and serious diseases. In 2013, AbbVie employs
approximately 21,000 people worldwide and markets medicines in more than 170
countries. For further information on the company and its people, portfolio
and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or
view careers on our Facebookor LinkedIn page.





SOURCE Abbott; AbbVie

Website: http://www.abbott.com
Website: http://www.abbvie.com
Contact: Abbott, Media, Scott Stoffel, +1-847-936-9502, or Financial, Brian
Yoor, +1-847-937-6343; or AbbVie, Media, Adelle Infante, +1-847-938-8745, or
Financial, Larry Peepo, +1-847- 935-6722